Search results
Results from the WOW.Com Content Network
World map of annual cannabis prevalence. This is a list of the annual prevalence of cannabis use by country (including some territories) as a percentage of the population. The indicator is an "annual prevalence" rate which is the percentage of the youth and adult population who have consumed cannabis at least once in the past survey year.
European Monitoring Centre for Drugs and Drug Addiction has an interactive cannabis use map of Europe. One can select by recall period: last month, last year, or lifetime. Also by age: young adults (15–34), or adults (15–64
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]
An interactive map showing how opioid abuse rates outpace treatment capacity 2 to 1. ... Live results of the 2012 marijuana legalization ballot measures.
An interactive map showing how opioid abuse rates outpace treatment capacity 2 to 1. 350 Miles For Treatment A HuffPost investigation into the dearth of treatment options available to opiate addicts living in rural America.
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders and ICD-10 as the continued use of cannabis despite clinically significant impairment. [2] [3]
A lot of the data around marijuana use and mental health focuses on people who are heavy pot users, making it difficult to say for certain how sporadic marijuana use will affect people, Hillary ...
Speaking before the National Advisory Council on Drug Abuse, Rob Kampia of the Marijuana Policy Project criticized NIDA for refusing to provide researcher Donald Abrams with marijuana for his studies, stating that "after nine months of delay, Leshner rejected Abrams' request for marijuana, on what we believe are political grounds that the FDA ...